Increasing relevance of acute cerebrovascular disease in very old patients.
Arboix
A
A
D017677:Age Distribution; D000367:Age Factors; D000369:Aged, 80 and over; D000375:Aging; D001281:Atrial Fibrillation / Q000453:epidemiology* / Q000503:physiopathology; D002545:Brain Ischemia / Q000453:epidemiology* / Q000503:physiopathology; D002543:Cerebral Hemorrhage / Q000175:diagnosis / Q000453:epidemiology / Q000503:physiopathology; D002561:Cerebrovascular Disorders / Q000453:epidemiology* / Q000503:physiopathology; D015897:Comorbidity; D005260:Female; D005343:Fibrinolytic Agents / Q000009:adverse effects; D006801:Humans; D008297:Male; D012307:Risk Factors; D020521:Stroke / Q000453:epidemiology* / Q000503:physiopathology; D010959:Tissue Plasminogen Activator / Q000009:adverse effects / Q000627:therapeutic use
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator